CD8A and myeloid sarcoma: However, the CD8+ Tnaïve-like response in MS-OCR patients was of slightly lower quality compared to HCs, as indicated by the lower co-expression of four and five dynamic markers following both vaccinations (Figure 5f and Figure 5—figure supplement 1e).